ADC Therapeutics SA Adjustments For Decrease Increase In Other Assets
ADC Therapeutics SA (ADCT) reported Adjustments For Decrease Increase In Other Assets of -$268.00 thousand for the 9-month period ending 2023-09-30, per its 6-K filed 2023-11-07.
Discontinued › Notes
ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets · last filed 2023-11-07
- ADC Therapeutics SA adjustments for decrease increase in other assets for the quarter ending 2023-09-30 was -$1.69M.
- ADC Therapeutics SA adjustments for decrease increase in other assets for the quarter ending 2023-06-30 was $1.37M, a 71.88% decline year-over-year.
- ADC Therapeutics SA adjustments for decrease increase in other assets for the quarter ending 2023-03-31 was $55.00K.
- ADC Therapeutics SA adjustments for decrease increase in other assets for the quarter ending 2022-09-30 was -$3.31M.
| Period end | Adjustments For Decrease Increase In Other Assets 3 month | Adjustments For Decrease Increase In Other Assets 6 month | Adjustments For Decrease Increase In Other Assets 9 month |
|---|---|---|---|
| 2023-09-30 | -$1.69M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | -$323.00K derived: sum of 2 quarters · filed 2023-11-07 | -$268.00K 6-K · filed 2023-11-07 |
| 2023-06-30 | $1.37M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-08 | $1.42M 6-K · filed 2023-08-08 | |
| 2023-03-31 | $55.00K 6-K · filed 2023-05-09 | ||
| 2022-09-30 | -$3.31M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | $1.55M derived: sum of 2 quarters · filed 2023-11-07 | $489.00K 6-K · filed 2023-11-07 |
| 2022-06-30 | $4.86M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-08 | $3.80M 6-K · filed 2023-08-08 | |
| 2022-03-31 | -$1.06M 6-K · filed 2023-05-09 | ||
| 2021-09-30 | -$1.76M derived: 6-K 9 month − 6-K 6 month · filed 2022-11-08 | -$4.47M derived: sum of 2 quarters · filed 2022-11-08 | -$3.40M 6-K · filed 2022-11-08 |
| 2021-06-30 | -$2.71M derived: 6-K 6 month − 6-K 3 month · filed 2022-08-09 | -$1.64M 6-K · filed 2022-08-09 | |
| 2021-03-31 | $1.07M 6-K · filed 2022-05-09 | ||
| 2020-09-30 | -$1.49M derived: 6-K 9 month − 6-K 6 month · filed 2021-11-02 | -$6.49M derived: sum of 2 quarters · filed 2021-11-02 | -$5.06M 6-K · filed 2021-11-02 |
| 2020-06-30 | -$5.00M derived: 6-K 6 month − 6-K 3 month · filed 2021-08-03 | -$3.57M 6-K · filed 2021-08-03 | |
| 2020-03-31 | $1.43M 6-K · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |